Barclays’s Innovator US Equity Accelerated Plus ETF January XTJA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-171
Closed -$5.21K – 5679
2026
Q1
$5.21K Sell
171
-1,745
-91% -$55K ﹤0.01% 4770
2025
Q4
$60.6K Sell
1,916
-2,892
-60% -$90.2K ﹤0.01% 4705
2025
Q3
$148K Sell
4,808
-257
-5% -$7.74K ﹤0.01% 4478
2025
Q2
$149K Buy
5,065
+3,414
+207% +$93.3K ﹤0.01% 4428
2025
Q1
$44.4K Buy
1,651
+284
+21% +$7.91K ﹤0.01% 4646
2024
Q4
$38K Buy
1,367
+917
+204% +$25.2K ﹤0.01% 4814
2024
Q3
$12.2K Buy
+450
New +$12K ﹤0.01% 4953

Other funds holding XTJA

Barclays's XTJA Position: Q2 2026 in Review

Barclays sold out of Innovator US Equity Accelerated Plus ETF January (XTJA) in Q2 2026, closing a stake of 171 shares — an estimated $5.21K sold.

Barclays first reported a position in XTJA in Q3 2024 and held it in 7 quarters. The position peaked at $149K in Q2 2025. 19 funds tracked by Wall St. Rank hold XTJA as of Q2 2026.

  • Barclays reported no remaining Innovator US Equity Accelerated Plus ETF January position as of Q2 2026 after selling out during the quarter.
  • Barclays sold 171 Innovator US Equity Accelerated Plus ETF January shares in Q2 2026, an estimated $5.21K.
  • Barclays first reported a position in Innovator US Equity Accelerated Plus ETF January in Q3 2024 and held it in 7 quarters.
  • Barclays's Innovator US Equity Accelerated Plus ETF January position peaked at $149K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held Innovator US Equity Accelerated Plus ETF January as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.